NGNE (STOCKS)
Neurogene, Inc. Common Stock
$19.280000
-1.100000 (-5.40%)
Prev close: $20.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rachel L. McMinn
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $299.96M
- Employees
- 107
- P/E (TTM)
- -4.09
- P/B (TTM)
- 1.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.17 | $-1.21 | +0.0423 | +3.49% |
|
Sep 2025 (Q3)
|
$-0.99 | $-1.28 | +0.2850 | +22.35% |
|
Jun 2025 (Q2)
|
$-1.05 | $-1.18 | +0.1317 | +11.15% |
|
Mar 2025 (Q1)
|
$-1.08 | $-1.08 | +0.0046 | +0.42% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $12.98M |
| Operating Expenses | $103.33M |
| Research and Development | $75.01M |
| Other Operating Expenses | $28.32M |
| Operating Income/Loss | -$103.33M |
| Income/Loss From Continuing Operations After Tax | -$90.35M |
| Income/Loss From Continuing Operations Before Tax | -$90.35M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$90.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$90.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$90.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.24 |
| Diluted Earnings Per Share | -$4.24 |
| Basic Average Shares | 21,326,283 |
| Diluted Average Shares | 21,326,283 |
| Assets | $288.60M |
| Current Assets | $271.77M |
| Cash | $269.00M |
| Prepaid Expenses | $1.94M |
| Other Current Assets | $832.00K |
| Noncurrent Assets | $16.83M |
| Fixed Assets | $12.79M |
| Other Non-current Assets | $4.04M |
| Liabilities | $23.72M |
| Current Liabilities | $16.41M |
| Accounts Payable | $1.95M |
| Wages | $5.07M |
| Other Current Liabilities | $9.39M |
| Noncurrent Liabilities | $7.31M |
| Equity | $264.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $264.89M |
| Liabilities And Equity | $288.60M |
| Net Cash Flow From Operating Activities | -$77.17M |
| Net Cash Flow From Operating Activities, Continuing | -$77.17M |
| Net Cash Flow From Investing Activities | $14.00M |
| Net Cash Flow From Investing Activities, Continuing | $14.00M |
| Net Cash Flow From Financing Activities | $30.43M |
| Net Cash Flow From Financing Activities, Continuing | $30.43M |
| Net Cash Flow | -$32.74M |
| Net Cash Flow, Continuing | -$32.74M |
| Comprehensive Income/Loss | -$90.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$90.35M |
| Other Comprehensive Income/Loss | $0.00 |